Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
OPKO Health, Inc. OPK
$1.71
-$0.07 (-4.21%)
На 18:00, 12 мая 2023
+104.68%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
1321233224.00000000
-
week52high
3.24
-
week52low
1.00
-
Revenue
1004200000
-
P/E TTM
-4769
-
Beta
1.67750800
-
EPS
-0.47000000
-
Last Dividend
0.00000000
-
Next Earnings Date
02 авг 2023 г. в 10:59
Описание компании
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Piper Sandler | Overweight | Overweight | 05 авг 2022 г. |
| Piper Sandler | Overweight | Overweight | 10 мая 2022 г. |
| Barrington Research | Market Perform | Outperform | 24 янв 2022 г. |
| Ladenburg Thalmann | Buy | 21 июн 2021 г. | |
| Piper Jaffray | Overweight | 25 ноя 2019 г. | |
| HC Wainwright & Co. | Buy | 15 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| FROST PHILLIP MD ET AL | A | 198831694 | 19655 | 22 ноя 2022 г. |
| FROST PHILLIP MD ET AL | A | 198812039 | 6345 | 22 ноя 2022 г. |
| FROST PHILLIP MD ET AL | A | 198805694 | 75496 | 22 ноя 2022 г. |
| FROST PHILLIP MD ET AL | A | 198730198 | 11551 | 22 ноя 2022 г. |
| FROST PHILLIP MD ET AL | A | 198718647 | 93500 | 22 ноя 2022 г. |
| FROST PHILLIP MD ET AL | A | 198625147 | 1200 | 22 ноя 2022 г. |
| FROST PHILLIP MD ET AL | A | 198623947 | 58006 | 22 ноя 2022 г. |
| FROST PHILLIP MD ET AL | A | 198565941 | 34247 | 22 ноя 2022 г. |
| FROST PHILLIP MD ET AL | A | 198531694 | 22927 | 09 ноя 2022 г. |
| FROST PHILLIP MD ET AL | A | 198508767 | 11573 | 09 ноя 2022 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | 10823641 | 1744961 | 30 сент 2022 г. |
| iShares Russell 2000 ETF | 8602950 | 246392 | 31 авг 2020 г. |
| iShares NASDAQ Biotechnology ETF | 6885120 | -45814 | 31 авг 2020 г. |
| iShares Russell 2000 Value ETF | 3519030 | 40482 | 31 авг 2020 г. |
| SPDR S&P Biotech ETF | 22369200 | -1151030 | 31 авг 2020 г. |
| Vanguard Total Stock Market Index Fund | 11232400 | -155118 | 31 авг 2020 г. |
| Vanguard Small-Cap Index Fund | 9976630 | -98463 | 31 июл 2020 г. |
| Vanguard Small-Cap Growth Index Fund | 6049800 | -38982 | 31 июл 2020 г. |
| Vanguard Extended Market Index Fund | 5898100 | -82591 | 31 июл 2020 г. |
| Statens Pensjonsfond Utland | 4327750 | 1268980 | 31 дек 2019 г. |
Новостная лента
OPKO Health's Future After Merck Deal: Bright Or Uncertain
Seeking Alpha
11 мая 2023 г. в 12:29
In the first three months of 2023, the company posted $237.6 million in revenue, up 28.2% from the previous quarter. In addition to the Merck deal, OPKO received a $7 million payment from Vifor in Q1 2023, thanks to the German price approval for Rayaldee.
7 Hot Penny Stocks Under $1.10 To Watch This Week
PennyStocks
08 мая 2023 г. в 15:18
Penny stocks to buy for under $1 but are they worth the risk? The post 7 Hot Penny Stocks Under $1.10 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Strong Small-Cap Insider Buys: Q1 2023
Seeking Alpha
26 апр 2023 г. в 00:15
Strong Small-Cap Insider Buys: Q1 2023.
OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023
GlobeNewsWire
25 апр 2023 г. в 16:05
MIAMI, April 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2023 after the close of the U.S. financial markets on Wednesday, May 3, 2023. OPKO's senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on May 3rd beginning at 4:30 p.m. Eastern time.
Opko's Phillip Frost May Be the Ultimate Insider, as Seen in Recent March Purchases
24/7 Wall Street
10 апр 2023 г. в 22:47
When it comes to insider transactions, there are few insiders as consistent — and successful — as OPKO Health ( US:OPK , IL:OPK) chairman and CEO Phillip Frost.